Stay updated on Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page.

Latest updates to the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.3 has been added to the page, replacing Revision: v3.4.2 in the revision history.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedThe page revision updated from v3.4.1 to v3.4.2; this appears to be a version-label change rather than a modification of core study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check43 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1. No substantive changes to the study details or page functionality are evident.SummaryDifference0.0%

- Check50 days agoChange DetectedShow glossary toggle and new labels 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0' while removing 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no changes to study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check86 days agoChange DetectedThe Locations section expanded with numerous new sites across multiple countries and regions, while many existing sites were removed, altering geographic coverage of the trial.SummaryDifference3%

Stay in the know with updates to Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Chemo +/- Pembrolizumab in Esophageal Cancer Clinical Trial page.